Biospace
Published November 17, 2026
Povofortay® (povorcitinib) Approved in Europe as the First Once-Daily Oral Treatment ... - BioSpace
Read the full story at Biospace
This press release contains forward-looking statements within the ... Psychedelics · Serious adverse events mar robust efficacy data for Helus'.
Surfaced by this Google Alert
- Psychedelic press release